Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer

References

• 1  Shirabe K, Shimada M, Matsumata T et al. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology50,1560–1563 (2003).
  MedlineGoogle Scholar
• 2  Marrelli D, Roviello F, de Stefano A et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. J. Am. Coll. Surg.198,51–58 (2004).
  MedlineGoogle Scholar
• 3  Whiting J, Sano T, Saka M, Fukagawa T, Katai H, Sasako M. Follow-up of gastric cancer: a review. Gastric Cancer9,74–81 (2006).
  MedlineGoogle Scholar
• 4  Fidler IJ, Naito S, Pathak S. Orthotopic implantation is essential for the selection, growth, and metastasis of human renal cancer in nude mice. Cancer Metastasis Rev.9,149–165 (1990).
  Medline CASGoogle Scholar
• 5  Furukawa T, Kubota T, Watanabe M, Kitagima M, Hoffman RM. A novel patient-like treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res.53,3070–3072 (1993).
  Medline CASGoogle Scholar
• 6  Vieweg J, Rosenthal FM, Bannerji R et al. Immunotherapy of prostate cancer in the dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res.54,1760–1765 (1994).
  Medline CASGoogle Scholar
• 7  Kleinerman DI, Dinney CP, Zhang WW, Lin SH, van NT, Hsieh JT. Suppression of human-bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res.56,3431–3435 (1996).
  Medline CASGoogle Scholar
• 8  Furukawa T, Kubota T, Watanabe M et al. A metastatic model of human colon cancer constructed using cecal implantation of cancer tissue in nude mice. Surg. Today23,420–423 (1993).
  Medline CASGoogle Scholar
• 9  Hoffman RM. Orthotopic metastatic models of anticancer drug discovery and evaluation: a bridge to the clinic. Invest. New Drugs17,343–359 (1999).
  Medline CASGoogle Scholar
• 10  Yamaguchi K, Ura H, Yasoshima T, Shishido T, Denno R, Hirata K. Liver metastatic model for human gastric cancer established by orthotopic tumour cell implantation. World J. Surg.25,131–137 (2001).
  Medline CASGoogle Scholar
• 11  Yanagihara K, Takigahira M, Tanaka H et al. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci.96,323–332 (2005).
  Medline CASGoogle Scholar
• 12  Enomoto T, Oda T, Aoyagi Y et al. Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells. Cancer Res.66,11131–11139 (2006).
  Medline CASGoogle Scholar
• 13  Amoh Y, Bouvet M, Li L et al. Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice. Clin. Exp. Metastasis23,315–322 (2006).
  MedlineGoogle Scholar
• 14  Frampas E, Maurel C, Thedrez P et al. The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody. Nucl. Med. Commun.32,147–154 (2011).
  Medline CASGoogle Scholar
• 15  Gallo RC, Whang-Peng J, Adamson RH. Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. J. Natl Cancer Inst.46,789–795 (1971).
  Medline CASGoogle Scholar
• 16  Li LH, Fraser TJ, Olin EJ, Bhuyan BK. Action of camptothecin on mammalian cells in culture. Cancer Res.32,2643–2650 (1972).
  Medline CASGoogle Scholar
• 17  Gottlieb JA, Guarino AM, Call JB, Oliverio VT, Block JB. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). Cancer Chemother. Rep.54,461–470 (1970).
  Medline CASGoogle Scholar
• 18  Muggia FM, Creaven PJ, Hansen HH, Cohen MH, Selawry OS. Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies. Cancer Chemother. Rep.56,515–521 (1972).
  Medline CASGoogle Scholar
• 19  Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumouritropic accumulation of proteins and the antitumor agent smancs. Cancer Res.46,6387–6392 (1986).
  Medline CASGoogle Scholar
• 20  Koizumi F, Kitagawa M, Negishi T et al. Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res.66,10048–10056 (2006).
  Medline CASGoogle Scholar
• 21  Sumitomo M, Koizumi F, Asano T et al. Novel SN-38-incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression. Cancer Res.68,1631–1635 (2008).
  Medline CASGoogle Scholar
• 22  Nakajima TE, Yasunaga M, Kano Y et al. Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil. Int. J. Cancer122,2148–2153 (2008).
  Medline CASGoogle Scholar
• 23  Saito Y, Yasunaga M, Kuroda J, Koga Y, Matsumura Y. Enhanced distribution of NK012, a polymeric micelle encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumor. Cancer Sci.99,1258–1264 (2008).
  Medline CASGoogle Scholar
• 24  Kuroda J, Kuratsu J, Yasunaga M, Koga Y, Saito Y, Matsumura Y. Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma. Int. J. Cancer124,2505–2511 (2009).
  Medline CASGoogle Scholar
• 25  Takahashi A, Ohkochi N, Yasunaga M et al. Detailed distribution of NK012, an SN-38-Incoporating micelle, in the liver and its potent antitumor effects in mice bearing liver metastases. Clin. Cancer Res.16,4822–4831 (2010).
  Medline CASGoogle Scholar
• 26  Kuroda J, Kuratsu J, Yasunaga M et al. Antitumor effect of NK012, a 7-ethyl-10-hydroxycamptothecin-incorporating polymeric micelle, on U87MG orthotopic glioblastoma in mice compared with irinotecan hydrochloride in combination with bevacizumab. Clin. Cancer Res.16,521–529 (2010).
  Medline CASGoogle Scholar
• 27  Nakajima TE, Yanagihara K, Takigahira M et al. Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan. Cancer Res.68,9318–9322 (2008).
  Medline CASGoogle Scholar
• 28  Yanagihara K, Tanaka H, Takigahira M et al. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci.95,575–582 (2004).
  Medline CASGoogle Scholar
• 29  Carbal H, Nishiyama N, Okazaki S, Koyama H, Kataoka K. Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum (II) (DACHPt)-loaded polymeric micelles. J. Control. Release101,223–232 (2005).
  MedlineGoogle Scholar
• 30  Yanagihara K, Kamada N, Tsumuraya M, Amano F. Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium. Int. J. Cancer54,200–207 (1993).
  Medline CASGoogle Scholar
• 31  Yanagihara K, Takigahira M, Takeshita F et al. A photon counting technique for quantitatively evaluating progression of peritoneal tumor dissemination. Cancer Res.66,7532–7539 (2006).
  Medline CASGoogle Scholar
• 32  Yanagihara K, Nii M, Tsumuraya M, Numoto M, Seito T, Seyama T. A radiation-induced murine ovarian granulose cell tumor line: introduction of v-ras gene potentiates a high metastatic ability. Jpn J. Cancer Res.86,347–356 (1995).
  Medline CASGoogle Scholar
• 33  Tiberio GA, Coniglio A, Marchet A et al. Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur. J. Surg. Oncl.35,486–491 (2009).
  Medline CASGoogle Scholar
• 34  Thelen A, Jonas S, Benckert C et al. Liver resection for metastatic gastric cancer. Eur. J. Surg. Oncol.34,1328–1334 (2008).
  Medline CASGoogle Scholar
• 35  Nashimoto A, Yabusaki H, Nakagawa S. Proper follow-up schedule after curative gastric surgery. Jpn J. Cancer Chemother.36,1402–1407 (2009).
  MedlineGoogle Scholar
• 36  Yasoshima T, Denno R, Kawaguchi S et al. Establishment and characterization of human gastric carcinoma lines with high metastatic potential in the liver: changes in integrin expression associated with the ability to metastasize in the liver of nude mice. Jpn J. Cancer Res.87,153–160 (1996).
  Medline CASGoogle Scholar
• 37  Nakanishi H, Yasui K, Ikehara Y et al. Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis. Clin. Exp. Metastasis22,137–147 (2005).
  Medline CASGoogle Scholar
• 38  Yokoyama H, Ikehara Y, Kodera Y et al. Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis. Br. J. Cancer95,1504–1513 (2006).
  Medline CASGoogle Scholar
• 39  Shen X, Jin W, Cui H et al. Cellular adjustment of gastric cancer for hepatic metastasis in successive orthotopic implantation model. Cancer Biol. Ther.5,1313–1319 (2006).
  Medline CASGoogle Scholar
• 40  Matsuoka T, Adair JE, Lih FB et al. Elevated dietary lioleic acid increases gastric carcinoma cell invasion and metastasis in mice. Br. J. Cancer103,1182–1191 (2010).
  Medline CASGoogle Scholar
• 41  Bang YJ, Van Cutsem E, Feyereislova A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a Phase III, open-label, randomised controlled trial. Lancet376,687–697 (2010).
  Medline CASGoogle Scholar
• 42  Jager E, van der Velden VH, te Marvelde JG, Walter RB, Agur Z, Vainstein V. Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization. PLoS ONE6(9),e24265 (2011).
  Medline CASGoogle Scholar
• 43  Li Y, Li B, Zhang Y, Xiang CP, Li YY, Wu XL. Serial observations on an orthotopic gastric cancer model constructed using improved implantation technique. World J. Gastroenterol.17,1442–1447 (2011).
  MedlineGoogle Scholar
• 44  Noguchi Y, Wu J, Duncan R et al. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J. Cancer Res.89,307–314 (1998).
  Medline CASGoogle Scholar
• 45  Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol.2,751–760 (2007).
  Medline CASGoogle Scholar